BioWorld - Monday, February 9, 2026

BioWorld Science

Aug. 17, 2021

View Archived Issues

Aberrant NAD+ metabolism underlies Zika microcephaly

Read More

Phase II study initiated to assess aspacytarabine in AML and MDS patients

Read More

Moderna initiates phase I/II study of mRNA-3705 for methylmalonic acidemia

Read More

Chengdu Biobel patents compounds for C. difficile infection

Read More

Chinese researchers divulge new PD-1/PD-L1 interaction inhibitors

Read More

Jasan Bio Medicine (Jiaxing) synthesizes new DHFR inhibitors

Read More

Clinical trial finds PRAX-114 improves symptoms of perimenopausal depression

Read More

AgeX Therapeutics describes new exosomes for wound healing

Read More

Neurodevelopmental disorders tied to genetic variation in CLCN3 gene

Read More

Inhibitors of TNF-alpha- and IL-6-induced adhesion show activity in IBD models

Read More

BBP-631 enters phase I/II for treating congenital adrenal hyperplasia

Read More

Initiation of phase II trial to assess TLX-66 for pediatric leukemia

Read More

Phase II study cleared to evaluate TQ Formula in COVID-19 patients

Read More

TRIDENT-2 study evaluates repotrectinib combined with trametinib in KRAS G12D mutant solid tumors

Read More

IND application accepted for phase I/Ib trial for CPI-818 for treating R/R T-cell lymphoma in China

Read More

Crovalimab evaluated for vaso-occlusive episodes in patients with sickle cell disease

Read More

Green light for censavudine to initiate phase II trial in neurodegeneration

Read More

Transient nanofibrillar hydrogels release glucagon under low-glucose conditions

Read More